Latest updates on treatments and challenges for immunocompromised adults, including FDA approvals and breakthroughs in antiviral-resistant herpes therapies.
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults